Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Serina Therapeutics, Inc. (SER) Operating Margin data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.34M |
|
-- |
|
-- |
|
$6.21M |
|
$-6.21M |
|
$2.89M |
|
$-3.32M |
|
$-3.32M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-6.21M |
|
$-6.12M |
|
10.19M |
|
10.19M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$6.08M |
|
$0.47M |
|
$0.87M |
|
$6.95M |
|
$3.56M |
|
$2.95M |
|
$3.42M |
|
$6.99M |
|
$-4.98M |
|
$-0.04M |
|
$-0.04M |
|
10.77M |
|
| Cash Flow Statement Financials | |
$-17.95M |
|
$-0.06M |
|
$17.41M |
|
$3.67M |
|
$3.06M |
|
$-0.62M |
|
$3.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.71 |
|
-- |
|
-- |
|
1.01 |
|
-79.62 |
|
-- |
|
|
Operating Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
$-18.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.03% |
|
9016.29% |
|
-47.99% |
|
-114.68% |
|
$-0.00 |
|
$-1.77 |
|
$-1.76 |
|